Appiah Grace D, Chaves Sandra S, Kirley Pam D, Miller Lisa, Meek James, Anderson Evan, Oni Oluwakemi, Ryan Patricia, Eckel Seth, Lynfield Ruth, Bargsten Marisa, Zansky Shelley M, Bennett Nancy, Lung Krista, McDonald-Hamm Christie, Thomas Ann, Brady Diane, Lindegren Mary L, Schaffner William, Hill Mary, Garg Shikha, Fry Alicia M, Campbell Angela P
Epidemic Intelligence Service and Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia;
California Emerging Infections Program, Oakland.
Clin Infect Dis. 2017 Feb 1;64(3):364-367. doi: 10.1093/cid/ciw745. Epub 2016 Nov 10.
(See the Editorial Commentary by Martin on pages 368-9.)Using population-based surveillance data, we analyzed antiviral treatment among hospitalized patients with laboratory-confirmed influenza. Treatment increased after the influenza A(H1N1) 2009 pandemic from 72% in 2010-2011 to 89% in 2014-2015 (P < .001). Overall, treatment was higher in adults (86%) than in children (72%); only 56% of cases received antivirals on the day of admission.
(见Martin在第368 - 369页的编辑评论。)利用基于人群的监测数据,我们分析了实验室确诊流感住院患者的抗病毒治疗情况。2009年甲型H1N1流感大流行后,治疗率从2010 - 2011年的72%上升至2014 - 2015年的89%(P <.001)。总体而言,成人的治疗率(86%)高于儿童(72%);只有56%的病例在入院当天接受了抗病毒药物治疗。